Methods to analyse cost data of patients who withdraw in a clinical trial setting.
about
Multiple imputation strategies for zero-inflated cost data in economic evaluations: which method works best?Effectiveness of computer-navigated minimally invasive total hip surgery compared to conventional total hip arthroplasty: design of a randomized controlled trialCost-effectiveness analysis of cognitive behaviour therapy for treatment of minor or mild-major depression in elderly patients with type 2 diabetes: study protocol for the economic evaluation alongside the MIND-DIA randomized controlled trial (MIND-Collaborative stepped care for anxiety disorders in primary care: aims and design of a randomized controlled trial.Sustained economic benefits of resistance training in community-dwelling senior women.Within-trial economic evaluation of diabetes-specific cognitive behaviour therapy in patients with type 2 diabetes and subthreshold depressionThe effectiveness of early lens extraction with intraocular lens implantation for the treatment of primary angle-closure glaucoma (EAGLE): study protocol for a randomized controlled trialA method to estimate off-schedule observations in a longitudinal study.Challenges with cost-utility analyses of behavioural interventions among older adults at risk for dementia.Randomised controlled trial of tailored interventions to improve the management of anxiety and depressive disorders in primary care.Action seniors! - secondary falls prevention in community-dwelling senior fallers: study protocol for a randomized controlled trial.Assessment of progression of COPD: report of a workshop held in Leuven, 11-12 March 2004Mobility predicts change in older adults' health-related quality of life: evidence from a Vancouver falls prevention prospective cohort study.Economic evaluation of dose-response resistance training in older women: a cost-effectiveness and cost-utility analysisMobility Is a Key Predictor of Change in Well-Being Among Older Adults Who Experience Falls: Evidence From the Vancouver Falls Prevention Clinic Cohort.Economic evaluations: a new avenue of outcome assessment in spinal disordersEconomic evaluation of aerobic exercise training in older adults with vascular cognitive impairment: PROMoTE trial.How to Appropriately Extrapolate Costs and Utilities in Cost-Effectiveness Analysis.Within and between race differences in lymphocyte, CD4+, CD8+ and neutrophil levels in HIV-uninfected children with or without HIV exposure in Europe and Uganda.Protocol for an economic evaluation of the randomised controlled trial of culprit lesion only PCI versus immediate multivessel PCI in acute myocardial infarction complicated by cardiogenic shock: CULPRIT-SHOCK trial.E-health in caring for patients with atopic dermatitis: a randomized controlled cost-effectiveness study of internet-guided monitoring and online self-management training.Handling Missing Data in Within-Trial Cost-Effectiveness Analysis: A Review with Future Recommendations.Cost differences for COPD with and without physician-diagnosis.Cost-utility of exercise therapy in adolescents and young adults suffering from the patellofemoral pain syndrome.Cost-utility analysis of a multidisciplinary strategy to manage osteoarthritis of the knee: economic evaluation of a cluster randomized controlled trial study.Study protocol for Vitality: a proof-of-concept randomised controlled trial of exercise training or complex mental and social activities to promote cognition in adults with chronic stroke.
P2860
Q31010327-BDECD94D-36D0-4235-8D71-98CCFED1E9BFQ33268790-42C67D8A-3828-4B66-9C9B-37C346EAD6DFQ33477135-0D6472E6-C1E6-44D6-AA43-87EC0066D166Q33500848-D347975E-32D9-4E2D-BC5B-86E8EB3CFCC9Q33604738-1728CB2A-1E7F-4D05-960A-7A4FC2FDCFC7Q33722817-DD5BE7F2-303C-4B81-87A5-F33B4AA0C337Q33909132-ED5B129B-7072-4019-A723-2DC4207F6DF3Q34777566-431B6998-14D5-4E81-99F4-9C5A01E31584Q35054331-0861DD85-5E9F-4E57-ADD7-6A7C0A9F1847Q35181511-60E4C661-57FF-4810-A53C-32BA4CDDD45AQ35530408-57E8D71D-7E8A-40EE-A3FD-CB53B367CB88Q35537594-4FAEE396-6E4D-4689-81B2-BAE8734AC1F0Q35848292-861836C3-54A4-4871-88D1-58AE79F45A38Q35867792-51E48721-B226-4123-A1B6-398E637CBA4FQ36011209-93A81524-27E2-474F-83B6-334AB7B90A3BQ36266814-DAFF1687-3715-4D15-BCA4-22280ACD94CDQ37728309-DEB9EF88-D691-4C8E-A2EF-11A0CB6BADB1Q38687870-9272F4C9-B995-4524-9631-D51675349AB5Q38879127-1BBA61E7-440E-491E-BA3E-B1F41B3FAD73Q47109645-B3AEB44B-0E1F-467E-B83E-7C593F6D3611Q48493538-5DEC8D15-BA36-40FF-9730-176469BBBB0EQ50016205-0B8B1C2E-6E4E-473B-A25C-DFBD0CBB69D7Q50793757-ACD6315D-F2DA-44C3-B4F8-EB87045D2E22Q51135944-53CF4D89-0C2B-4BB9-B3F0-0A30F57B6BAFQ51771769-3C0AB9C0-64E4-44A5-B161-20E6478EAE9AQ52351629-EFE0D754-8847-442C-B947-CFF00CC8FF46
P2860
Methods to analyse cost data of patients who withdraw in a clinical trial setting.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Methods to analyse cost data of patients who withdraw in a clinical trial setting.
@ast
Methods to analyse cost data of patients who withdraw in a clinical trial setting.
@en
type
label
Methods to analyse cost data of patients who withdraw in a clinical trial setting.
@ast
Methods to analyse cost data of patients who withdraw in a clinical trial setting.
@en
prefLabel
Methods to analyse cost data of patients who withdraw in a clinical trial setting.
@ast
Methods to analyse cost data of patients who withdraw in a clinical trial setting.
@en
P2093
P1433
P1476
Methods to analyse cost data of patients who withdraw in a clinical trial setting.
@en
P2093
Jan B Oostenbrink
Maiwenn J Al
Maureen P M H Rutten-van Mölken
P304
P356
10.2165/00019053-200321150-00004
P577
2003-01-01T00:00:00Z
P6179
1037649601